Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Atlas Venture
Biotech
Atlas raises $400M for existing biotech portfolio
Atlas' Opportunity Fund III is designed to help the VC’s portfolio companies progress their investigational candidates.
Gabrielle Masson
Sep 4, 2025 10:22am
Scorpion spinout Antares raises $177M for preclinical portfolio
Jun 10, 2025 10:07am
George Church spinout restructures, considers strategic options
Mar 13, 2025 2:00pm
Atlas unveils a new $450M fund targeted at biotechs
Dec 5, 2024 8:40am
Judo throws down $100M to knock out kidney disease
Oct 7, 2024 10:42am
Kailera launches with $400M series A, 4 Chinese obesity drugs
Oct 1, 2024 8:30am
